Seiji Ueda Selected Research

Vascular System Injuries

3/2015	Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients.
8/2006	Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
5/2003	Smad protein and TGF-beta signaling in vascular smooth muscle cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seiji Ueda Research Topics

Disease

21	Chronic Renal Insufficiency 01/2024 - 08/2006
15	Diabetic Nephropathies (Diabetic Nephropathy) 12/2020 - 12/2004
13	Proteinuria 01/2024 - 01/2009
9	Cardiovascular Diseases (Cardiovascular Disease) 12/2014 - 06/2007
7	Fibrosis (Cirrhosis) 01/2024 - 05/2007
7	Atherosclerosis 03/2015 - 06/2005
6	Inflammation (Inflammations) 01/2024 - 04/2007
6	Chronic Kidney Failure (Chronic Renal Failure) 09/2017 - 07/2006
4	Albuminuria 10/2023 - 05/2016
4	Hypertension (High Blood Pressure) 09/2021 - 08/2006
4	Hyperglycemia 12/2020 - 01/2008
4	Spinal Cord Compression 12/2018 - 01/2017
4	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2008 - 06/2005
3	Spinal Cord Diseases 09/2023 - 11/2005
3	Kyphosis 09/2023 - 01/2018
3	Anemia 12/2019 - 09/2017
3	Lordosis 12/2018 - 01/2018
3	Vascular System Injuries 03/2015 - 05/2003
3	Renal Insufficiency (Renal Failure) 04/2012 - 01/2009
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2024 - 01/2011
2	Disease Progression 01/2024 - 01/2012
2	Pain (Aches) 12/2022 - 03/2012
2	Pathologic Constriction (Stenosis) 06/2022 - 11/2005
2	COVID-19 11/2021 - 05/2021
2	Type 2 Diabetes Mellitus (MODY) 12/2020 - 09/2013
2	Acute Kidney Injury (Acute Renal Failure) 03/2020 - 01/2009
2	Cardio-Renal Syndrome 12/2019 - 01/2014
2	Non-alcoholic Fatty Liver Disease 11/2015 - 02/2014
2	Insulin Resistance 02/2014 - 02/2009
2	Hypertrophy 09/2013 - 12/2004
2	Dyslipidemias (Dyslipidemia) 01/2010 - 12/2009
2	Diabetic Angiopathies (Diabetic Angiopathy) 07/2008 - 01/2008
1	Constipation 09/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2021
1	Respiratory Insufficiency (Respiratory Failure) 05/2021
1	Cerebral Infarction 05/2021

Drug/Important Bio-Agent (IBA)

25	Advanced Glycation End ProductsIBA 10/2020 - 12/2004
18	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 09/2017 - 08/2006
9	Proteins (Proteins, Gene)FDA Link 10/2014 - 05/2003
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2019 - 06/2007
6	Nitric Oxide Synthase (NO Synthase)IBA 03/2014 - 04/2009
5	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2007
5	CreatinineIBA 01/2021 - 01/2009
5	AlbuminsIBA 01/2021 - 04/2009
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 08/2007
3	Interleukin-6 (Interleukin 6)IBA 11/2021 - 12/2009
3	CytokinesIBA 05/2021 - 08/2007
3	Telmisartan (Micardis)FDA Link 05/2016 - 01/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 01/2008
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2012 - 04/2007
3	CholesterolIBA 01/2011 - 12/2009
3	PPAR gammaIBA 07/2010 - 01/2008
3	LipidsIBA 01/2010 - 04/2007
2	Angiotensin IIIBA 01/2024 - 06/2005
2	Uric Acid (Urate)IBA 01/2021 - 01/2011
2	C-Reactive ProteinIBA 01/2021 - 03/2011
2	Nucleotide AptamersIBA 10/2020 - 09/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019 - 01/2008
2	trimethyloxamine (trimethylamine N-oxide)IBA 12/2019 - 03/2015
2	Erythropoietin FDA Link 10/2018 - 09/2017
2	Carnitine (L-Carnitine)FDA LinkGeneric 03/2015 - 12/2014
2	Receptor for Advanced Glycation End ProductsIBA 02/2014 - 11/2009
2	HDL CholesterolIBA 03/2013 - 01/2010
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2013 - 01/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2012 - 05/2009
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2012 - 09/2010
2	Triglycerides (Triacylglycerol)IBA 01/2011 - 01/2010
2	Nifedipine (Adalat)FDA LinkGeneric 07/2010 - 07/2009
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 07/2010 - 07/2009
2	Fatty Acid-Binding ProteinsIBA 01/2010 - 12/2009
2	Ezetimibe (Zetia)FDA Link 01/2010 - 12/2009
2	8-Hydroxy-2'-DeoxyguanosineIBA 01/2010 - 12/2009
2	LigandsIBA 12/2009 - 11/2009
2	dimethylargininaseIBA 06/2009 - 05/2007
2	pigment epithelium-derived factorIBA 05/2009 - 06/2005
2	Transforming Growth Factor beta (TGF-beta)IBA 04/2009 - 12/2004
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2009 - 04/2007
2	Angiotensin II Type 1 Receptor BlockersIBA 01/2008 - 01/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2008 - 08/2007
2	AST 120IBA 12/2006 - 07/2006
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2006 - 05/2003
1	Endothelins (Endothelin)IBA 01/2024
1	sparsentanIBA 01/2024
1	Angiotensin Receptor AntagonistsIBA 01/2024
1	Endothelin-1 (Endothelin 1)IBA 01/2024
1	Losartan (Cozaar)FDA LinkGeneric 01/2024
1	SteroidsIBA 11/2023
1	SodiumIBA 10/2023
1	dapagliflozinIBA 10/2023
1	Oxygen (Dioxygen)IBA 11/2021
1	Dietary PotassiumIBA 09/2021
1	SaltsIBA 09/2021

Therapy/Procedure

7	Laminectomy 09/2023 - 01/2017
7	Renal Dialysis (Hemodialysis) 09/2021 - 01/2008
6	Therapeutics 11/2023 - 01/2008
5	Laminoplasty 04/2018 - 11/2005
4	Decompression 06/2022 - 11/2005
2	Activities of Daily Living (ADL) 12/2022 - 01/2020
2	Peritoneal Dialysis 05/2021 - 10/2014
1	Plasma Exchange 05/2021